EXPERIMENTAL CONDITION - ANNOTATIONS
The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml ).
Term: surgical manipulation
Accession: XCO:0000165
browse the term
Definition: Any process involving manual and instrumental techniques for incision or excision of a part of an organism to investigate and/or treat a pathological condition.
Q
Vnigr1
Vascular neointimal growth QTL 1
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:149,040,888...168,026,850
Q
Vnigr2
Vascular neointimal growth QTL 2
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:130,656,562...169,034,231
Q
Vnigr3
Vascular neointimal growth QTL 3
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:130,656,562...169,034,231
Q
Salc1
Saline consumption QTL 1
IDA
RGD
PMID:15252022
RGD:1302889
NCBI chr 4:44,463,908...148,090,542
Q
Salc2
Saline consumption QTL 2
IDA
RGD
PMID:15252022
RGD:1302889
NCBI chr19:27,530,207...37,947,399
Q
Bp49
Blood pressure QTL 49
IDA
RGD
PMID:9241273
RGD:61056
NCBI chr 5:60,293,434...98,603,051
Q
Rf55
Renal function QTL 55
IDA
RGD
PMID:16303858
RGD:1579884
NCBI chr 1:218,748,008...257,976,495
Q
Rf56
Renal function QTL 56
IDA
RGD
PMID:16303858
RGD:1579884
NCBI chr 1:245,907,761...257,976,495
Q
Neudeg1
Neurodegradation QTL 1
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 8:30,188,867...94,457,446
Q
Neudeg2
Neurodegradation QTL 2
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:24,838,710...44,045,280
Q
Neuinf1
Neuroinflammation QTL 1
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:154,828,214...166,875,058
Q
Neuinf10
Neuroinflammation QTL 10
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr11:31,239,134...78,851,519
Q
Neuinf11
Neuroinflammation QTL 11
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 3:15,005,422...76,927,699
Q
Neuinf12
Neuroinflammation QTL 12
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr15:1...55,302,115
Q
Neuinf2
Neuroinflammation QTL 2
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr10:6,154,377...6,357,896
Q
Neuinf3
Neuroinflammation QTL 3
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr10:3,406,320...5,387,112
Q
Neuinf4
Neuroinflammation QTL 4
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 1:1...28,736,750
Q
Neuinf5
Neuroinflammation QTL 5
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 7:9,462,246...58,265,113
Q
Neuinf6
Neuroinflammation QTL 6
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 7:1...27,829,089
Q
Neuinf7
Neuroinflammation QTL 7
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr10:72,224,939...107,211,142
Q
Neuinf8
Neuroinflammation QTL 8
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 1:57,336,763...151,090,257
Q
Neuinf9
Neuroinflammation QTL 9
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr10:5,801,990...62,146,030
Q
Coreg1
Compensatory renal growth QTL 1
IDA
RGD
PMID:10732705
RGD:69708
NCBI chr 6:35,691,618...57,730,540
Q
Coreg2
Compensatory renal growth QTL 2
IDA
RGD
PMID:10864582
RGD:61071
NCBI chr 4:148,423,102...157,580,971
Q
Hcar1
Hepatocarcinoma resistance QTL 1
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr10:6,154,182...15,990,232
Q
Hcar10
Hepatocarcinoma resistance QTL 10
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 8:40,713,066...82,925,667
Q
Hcar11
Hepatocarcinoma resistance QTL 11
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 6:82,523,650...110,548,006
Q
Hcar12
Hepatocarcinoma resistance QTL 12
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 3:29,463,235...118,376,539
Q
Hcar13
Hepatocarcinoma resistance QTL 13
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 4:1...32,584,199
Q
Hcar14
Hepatocarcinoma resistance QTL 14
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr18:51,464,733...83,218,561
Q
Hcar2
Hepatocarcinoma resistance QTL 2
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 4:78,878,504...123,878,504
Q
Hcar3
Hepatocarcinoma resistance QTL 3
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 8:54,237,644...99,103,503
Q
Hcar9
Hepatocarcinoma resistance QTL 9
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 4:109,866,907...167,139,601
Q
Hcas1
Hepatocarcinoma susceptibility QTL 1
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 7:91,412,594...129,807,172
Q
Hcas2
Hepatocarcinoma susceptibility QTL 2
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 1:5,925,874...115,540,829
Q
Hcas3
Hepatocarcinoma susceptibility QTL 3
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 1:144,267,353...222,987,745
Q
Hcas4
Hepatocarcinoma susceptibility QTL 4
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr16:4,227,609...46,975,965
Q
Hcas5
Hepatocarcinoma susceptibility QTL 5
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 1:176,426,412...257,976,495
Q
Hcas6
Hepatocarcinoma susceptibility QTL 6
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr14:39,057,237...83,368,335
Q
Hcas7
Hepatocarcinoma susceptibility QTL 7
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr15:2,266,368...46,921,453
Q
Lnnr1
Liver neoplastic nodule remodeling QTL 1
IDA
RGD
PMID:12672032
RGD:629574
NCBI chr 7:34,293,282...79,293,282
Q
Lnnr2
Liver neoplastic nodule remodeling QTL 2
IDA
RGD
PMID:12672032
RGD:629574
NCBI chr 1:233,948,574...260,522,016
Q
Lnnr3
Liver neoplastic nodule remodeling QTL 3
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 2:1...41,244,106
Q
Lnnr4
Liver neoplastic nodule remodeling QTL 4
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:1...42,356,786
Q
Lnnr5
Liver neoplastic nodule remodeling QTL 5
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:59,874,408...85,581,182
Q
Lnnr6
Liver neoplastic nodule remodeling QTL 6
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:74,862,117...85,581,182
Q
Insul2
Insulin level QTL 2
IDA
RGD
PMID:9819774
RGD:69703
NCBI chr20:6,691,706...17,489,458
Q
Niddm37
Non-insulin dependent diabetes mellitus QTL 37
IDA
RGD
PMID:10218444
RGD:619676
NCBI chr14:11,030,622...95,876,975
Q
Niddm38
Non-insulin dependent diabetes mellitus QTL 38
IDA
RGD
PMID:10218444
RGD:619676
NCBI chr19:10,323,180...23,069,265
Q
Niddm39
Non-insulin dependent diabetes mellitus QTL 39
IDA
RGD
PMID:10218444
RGD:619676
NCBI chr 3:94,856,903...159,898,684
Q
Pancm5
Pancreatic morphology QTL 5
IDA
RGD
PMID:9745032
RGD:69697
NCBI chr14:30,320,092...80,829,842
Q
Pur12
Proteinuria QTL 12
IDA
RGD
PMID:16390874
RGD:1578625
NCBI chr 2:112,103,657...148,076,632
Q
Pur13
Proteinuria QTL 13
IDA
RGD
PMID:16390874
RGD:1578625
NCBI chr 3:78,196,190...146,592,722
Q
Pur14
Proteinuria QTL 14
IDA
RGD
PMID:16390874
RGD:1578625
NCBI chr17:7,979,968...16,317,111
Q
Pur15
Proteinuria QTL 15
IDA
RGD
PMID:16390874
RGD:1578625
NCBI chr20:8,042,410...17,617,956
Q
Rf52
Renal function QTL 52
IDA
RGD
PMID:16541022
RGD:1578626
NCBI chr 1:232,156,370...259,647,894
Q
Rf53
Renal function QTL 53
IDA
RGD
PMID:16541022
RGD:1578626
NCBI chr 3:56,395,968...161,299,569
Q
Rf59
Renal function QTL 59
IDA
RGD
PMID:21127141
RGD:5684423
NCBI chr 3:140,069,424...146,976,080
Q
Pain1
Pain QTL 1
IDA
RGD
PMID:17560719
RGD:1643003
NCBI chr 2:26,999,571...48,268,661
Q
Pain2
Pain QTL 2
IDA
RGD
PMID:17560719
RGD:1643003
NCBI chr 7:9,462,246...98,011,544
Q
Pain1
Pain QTL 1
IDA
RGD
PMID:17560719
RGD:1643003
NCBI chr 2:26,999,571...48,268,661
Q
Pain2
Pain QTL 2
IDA
RGD
PMID:17560719
RGD:1643003
NCBI chr 7:9,462,246...98,011,544
Q
Eae35
Experimental allergic encephalomyelitis QTL 35
IDA
RGD
PMID:24312603
RGD:8662358
NCBI chr 4:100,834,579...103,761,084
Q
Edpm1
Estrogen-dependent pituitary mass QTL 1
IDA
RGD
PMID:9337394
RGD:61074
NCBI chr 2:35,134,841...88,029,593
Q
Edpm10
Estrogen-dependent pituitary mass QTL 10
IDA
RGD
PMID:9337394
RGD:61074
Q
Edpm2
Estrogen-dependent pituitary mass QTL 2
IDA
RGD
PMID:9337394
RGD:61074
NCBI chr 2:76,539,322...202,447,032
Q
Edpm3
Estrogen-dependent pituitary mass QTL 3
IDA
RGD
PMID:9337394
RGD:61074
NCBI chr 3:53,184,692...89,878,207
Q
Edpm5
Estrogen-dependent pituitary mass QTL 5
IDA
RGD
PMID:9337394
RGD:61074
NCBI chr 5:68,984,307...104,251,008
Q
Edpm9
Estrogen-dependent pituitary mass QTL 9
IDA
RGD
PMID:9337394
RGD:61074
NCBI chr 9:63,869,687...108,869,687
Q
Emca10
Estrogen-induced mammary cancer QTL 10
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr 6:16,536,140...61,536,140
Q
Ept1
Estrogen-induced pituitary tumorigenesis QTL 1
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr 6:9,843,312...20,338,915
Q
Ept10
Estrogen-induced pituitary tumorigenesis QTL 10
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr 1:192,825,253...243,914,732
Q
Ept13
Estrogen-induced pituitary tumorigenesis QTL 13
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr 1:77,494,165...122,494,165
Q
Ept15
Estrogen-induced pituitary tumorigenesis QTL 15
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr 6:9,843,312...20,338,915
Q
Ept16
Estrogen-induced pituitary tumorigenesis QTL 16
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr 3:47,233,430...110,362,260
Q
Ept17
Estrogen-induced pituitary tumorigenesis QTL 17
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr 3:6,537,645...10,778,823
Q
Ept18
Estrogen-induced pituitary tumorigenesis QTL 18
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr10:73,453,136...96,120,911
Q
Ept2
Estrogen-induced pituitary tumorigenesis QTL 2
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr 3:47,233,430...110,362,260
Q
Ept5
Estrogen-induced pituitary tumorigenesis QTL 5
IDA
RGD
PMID:17876666
RGD:1642526
NCBI chr 4:83,428,419...177,635,233
Q
Ept6
Estrogen-induced pituitary tumorigenesis QTL 6
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr 3:6,537,645...10,778,823
Q
Ept7
Estrogen-induced pituitary tumorigenesis QTL 7
IDA
RGD
PMID:17876666
RGD:1642526
NCBI chr 7:62,004,452...101,773,158
Q
Ept9
Estrogen-induced pituitary tumorigenesis QTL 9
IDA
RGD
PMID:15687265
RGD:1334449
NCBI chr10:73,453,136...96,120,911
Q
Bp283
Blood pressure QTL 283
IDA
RGD
PMID:11053483
RGD:70856
Q
Rf3
Renal disease susceptibility QTL 3
IDA
RGD
PMID:11053483
RGD:70856
NCBI chr 3:107,693,393...152,693,393
Q
Rf4
Renal disease susceptibility QTL 4
IDA
RGD
PMID:11053483
RGD:70856
NCBI chr14:1...32,754,612
Q
Rf5
Renal disease susceptibility QTL 5
IDA
RGD
PMID:11053483
RGD:70856
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all